On the contrary, the patients in the SYNERGY study used to construct our model were mostly of African descent, infected by HCV genotype 1a, 32% with F3-4 fibrosis and only 20% had the IL28B CC genotype (Table S1), which are unfavorable factors for SVR. The gene discussed is IFNL3; the disease is fibrosis.